1. Home
  2. PFX vs CPIX Comparison

PFX vs CPIX Comparison

Compare PFX & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFX

PhenixFIN Corporation

N/A

Current Price

$47.09

Market Cap

88.9M

Sector

Finance

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$6.91

Market Cap

92.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFX
CPIX
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.9M
92.3M
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
PFX
CPIX
Price
$47.09
$6.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.3K
98.6K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
3.57%
N/A
EPS Growth
N/A
58.70
EPS
0.30
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$156.03
N/A
Revenue Growth
N/A
16.75
52 Week Low
$38.30
$1.85
52 Week High
$56.48
$9.28

Technical Indicators

Market Signals
Indicator
PFX
CPIX
Relative Strength Index (RSI) 44.56 42.52
Support Level $42.03 $5.55
Resistance Level $47.81 $7.36
Average True Range (ATR) 2.02 0.64
MACD -0.36 -0.14
Stochastic Oscillator 2.69 16.96

Price Performance

Historical Comparison
PFX
CPIX

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: